Cargando…

Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study

INTRODUCTION: Despite rasburicase's proven efficiency in Caucasians, Japanese, and Koreans, studies evaluating the safety and effectiveness of rasburicase in Chinese pediatric patients with non-Hodgkin’s lymphoma (NHL) and acute leukemia (AL) in particular are lacking. OBJECTIVE: The aim was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tianyou, Zhu, Xiaofan, Chen, Yumei, Shen, Shuhong, Tang, Yongmin, Zhang, Jingying, He, Yingyi, Zhang, Hui, Gao, Ju, Fang, Jianpei, Liu, Rong, Wu, Xiaoyan, Sun, Jinchuan, Zhang, Minlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293550/ https://www.ncbi.nlm.nih.gov/pubmed/37165291 http://dx.doi.org/10.1007/s40268-023-00420-y

Ejemplares similares

Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Alessa, Mohammed A., et al.
Publicado: (2015)

Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
por: Cammalleri, Lisa, et al.
Publicado: (2007)

Rasburicase-Induced Methemoglobinemia
por: Ahmed, Moeed, et al.
Publicado: (2021)

Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
por: Pession, Andrea, et al.
Publicado: (2008)

Not the Typical Pneumonia: An Unusual Case of Rasburicase-induced Methomoglobinemia
por: Younis, Moustafa, et al.
Publicado: (2018)

Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
por: Alakel, Nael, et al.
Publicado: (2017)

Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy
por: Dinnel, Jennifer, et al.
Publicado: (2015)

Rasburicase‐induced methemoglobinemia: case report, literature review, and proposed treatment algorithm
por: Sherwood, Garrett B., et al.
Publicado: (2016)

Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies
por: Pei, Yuxin, et al.
Publicado: (2020)

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study
por: Shi, Yuan-Kai, et al.
Publicado: (2021)

Single dose rasburicase in the management of tumor lysis syndrome in childhood acute lymphoblastic leukemia: A case series
por: Latha, S. M., et al.
Publicado: (2015)

An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma
por: Li, Ling, et al.
Publicado: (2018)

Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies
por: Kennedy, LeAnne D, et al.
Publicado: (2011)

A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
por: Viel, Sébastien, et al.
Publicado: (2018)

Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS
por: Raru, Yonas, et al.
Publicado: (2018)

Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report
por: Mouri, Yoshihiro, et al.
Publicado: (2022)

Dissolution of extensive urolithiasis: extending the utility of rasburicase can avoid the need for surgical intervention and renal replacement therapy
por: Rezvani, Sean, et al.
Publicado: (2016)

Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database
por: Kobayashi, Shunsuke, et al.
Publicado: (2022)

Rasburicase-Induced Falsely Low Measurement of Uric Acid in Tumor Lysis Syndrome: A Report of Two Cases
por: Yu, Lian, et al.
Publicado: (2023)

Pax5 expression in non-Hodgkin's lymphomas and acute leukemias.
por: Zhang, Xianglan, et al.
Publicado: (2003)

Effect of Akimbo versus Raised Arm Positioning on Breast and Cardiopulmonary Dosimetry in Pediatric Hodgkin Lymphoma
por: Denniston, Kyle A., et al.
Publicado: (2016)

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma
por: Andorsky, David J., et al.
Publicado: (2018)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

The correlation between dietary inflammatory index and risk of hyperuricemia in the U.S. population
por: Wang, Lijuan, et al.
Publicado: (2023)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review
por: Polepole, Pascal, et al.
Publicado: (2021)

Advances in the treatment of Hodgkin's lymphoma (Review)
por: Che, Yuxuan, et al.
Publicado: (2023)

The influence of marital status on the survival of patients with Hodgkin lymphoma
por: Wang, Fangfang, et al.
Publicado: (2017)

Mysterious Arm Swelling in a Patient With Non-Hodgkin Lymphoma Complicated by Superior Vena Cava Syndrome
por: Jang, Jessica S., et al.
Publicado: (2022)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
por: Liu, Jia, et al.
Publicado: (2018)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies
por: Robinson, Katherine M., et al.
Publicado: (2018)

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study
por: Ma, Xinran, et al.
Publicado: (2020)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
por: Kiani, Hadis, et al.
Publicado: (2016)

Composite Classical Hodgkin Lymphoma and Mantle Cell Lymphoma: A Case Report
por: Kaur, Rajdeep, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8nqd0ahsfjhvnlqbaidluggaep